Rheumatology

Limited access to exercise equipment and facilities during lockdown appears to be a key reason for reduced physical activity levels.

Interstitial lung disease (ILD), created by inflammation that leads to scarring of the lungs, causes shortness of breath, dry cough, and fatigue; data show it doubles mortality risk in rheumatoid arthritis (RA).

Circulating Interleukin-11 is difficult to detect in healthy individuals, but when it is present in various inflammatory diseases, it has an elevated present in affected tissues, according to a literature review.

New research found that residual inflammation in ultrasound images was associated with patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA) with low disease activity, but not in patients in remission.

A new sub-analysis suggested eating foods with anti-inflammatory properties may improve physical functioning in patients with rheumatoid arthritis.

Abstracts from American College of Rheumatology Convergence 2021 showed whether gender can impact the effectiveness of secukinumab in patients with ankylosing spondylitis (AS) or psoriatic arthritis (PsA).

Data outline prevalence of COVID-19 breakthrough and long haul infections among patients with rheumatic diseases.

Biological markers collected early in the disease course of rheumatoid arthritis could help improve patient management, researchers said.

If FDA approved for children, secukinumab (Cosentyx) will be the first biologic treatment for children in the US living with enthesitis-related arthritis.

The most common health care disruption found in the study was the replacement of face-to-face consultations with over-the-phone appointments.

The review found an association between systemic inflammatory disorders and increased risk of cardiovascular disease, encouraging discussions with patients regarding statin therapy.

Most early glucocorticoid treatment was targeted to patients with the most severe or active disease, according to study results from Canada.

Patients with axial spondyloarthritis treated with secukinumab achieved a reduction in spinal pain and improved disease activity measures early in treatment.

Researchers hope these findings help develop methods to assess cognitive function in patients with rheumatoid arthritis.

A new opinion piece makes the case that rheumatoid arthritis care can, and should, be better tailored to individual case characteristics.

Results of a pooled analysis showed patients with rheumatoid arthritis who take upadacitinib may be at increased risk of herpes zoster.

Three-quarters of patients said they were worried about the risks associated with SARS-CoV-2 infection.

Duration of rheumatoid arthritis and use of corticosteroids were associated with higher risk of adverse outcomes following coronary artery bypass graft (CABG).

Patients with rheumatoid arthritis (RA) who suffer from malnutrition were more likely to be frail and face mental health challenges.

A look at the existing literature suggests more questions than answers remain when it comes to the potential use of the cholinergic anti-inflammatory pathway in connective tissue diseases (CTDs).

The reports suggest patients with rheumatoid arthritis (RA) could experience secondary neurological adverse events, though the side effect appears to be rare.

Patients with rheumatoid arthritis (RA) who used tumor necrosis factor (TNF) inhibitors had significantly higher rates of nonmelanoma skin cancer and non-Hodgkin lymphoma.

A new study lends insights into the prevalence of lung abnormalities in patients with newly diagnosed cases of rheumatoid arthritis (RA).

In pediatric patients with frequently relapsing nephrotic syndrome (FRNS), the therapy was well tolerated, but did not lead to significant changes in disease course.

The new study, based on an analysis of existing literature and a replication cohort, helps clarify the role of a variant in microRNA-146a.

People who suffered trauma as a child appear to be at a higher risk of fibromyalgia, although it is unclear exactly why.

Patients with axial spondyloarthritis waited the longest, according to new research.

Rheumatology and nephrology experts provide an overview of the pharmacologic treatment options in lupus nephritis and discuss recent FDA approved therapies belimumab and voclosporin.

Results from the FUTURE 5 study show that more than 80% of patients had no radiographic progression of psoriatic arthritis, regardless of dose cohort or whether a loading dose was used.

Ellen Ginzler, MD, MPH, and German Hernandez, MD, FASN, FACP, discuss key drivers of healthcare utilization, progression of patients to end stage renal disease, and goals of treatment for lupus nephritis.